Paper Details

  1. Home
  2. Paper Details

[Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].

Author: FrancesconiM, GeyerG, HaidingerG, KunzeM, LangmayrN, PragerR, SchoberbergerR, ToplakH, von KalckreuthG

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Dexfenfluramine, an appetite suppressant, was found to be effective in reducing weight in obese individuals following a calorie-restricted diet. It was well tolerated with minimal side effects.
Paper Details　
Original Abstract of the Article :
In a multicenter study by 243 practicing physicians in Austria 819 severely obese subjects of both sexes without overt disease were encouraged to keep a calorie-restricted diet to reduce weight. After a run-in period of more than two weeks of dieting patients started taking 15 mg dexfenfluramine (Is...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8651045

データ提供：米国国立医学図書館（NLM）

Dexfenfluramine: A Potential Oasis in the Desert of Obesity

Obesity, a widespread health concern, is a complex challenge with far-reaching consequences. This research investigates the potential of dexfenfluramine, a medication that influences appetite and eating habits, as a tool to combat obesity. Imagine a vast desert where overindulgence leads to a scarcity of resources, akin to the consequences of obesity. This research explores a potential solution, dexfenfluramine, to help individuals navigate this challenging landscape and regain control over their health.

Dexfenfluramine: A Guide in the Desert of Obesity

The study found that dexfenfluramine effectively promoted weight loss in obese individuals, suggesting that it can be a valuable tool for managing obesity. Think of a caravan equipped with a skilled guide, able to navigate the treacherous desert terrain and lead the way towards a healthier path. This research indicates that dexfenfluramine may serve as a guide, helping individuals overcome the challenges of obesity and achieve a healthier weight.

Navigating the Desert of Weight Loss: The Importance of Lifestyle Modifications

While dexfenfluramine may offer a potential solution, it is crucial to remember that maintaining a healthy weight requires a comprehensive approach. This includes adopting a healthy lifestyle, incorporating regular exercise and a balanced diet, much like a caravan preparing for a long desert journey. This research should not be interpreted as a quick fix, but rather as a tool that can be used in conjunction with other strategies to combat obesity.

Dr.Camel's Conclusion

This research provides evidence for the potential of dexfenfluramine as a therapeutic option for managing obesity, offering a beacon of hope for individuals seeking to reclaim their health. It underscores the need for a holistic approach, combining medication with healthy lifestyle choices, to effectively address the challenges of obesity. The journey through the desert of obesity is long and arduous, but with the right tools and strategies, individuals can navigate towards a healthier future.

Date :
  1. Date Completed 1996-07-19
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

8651045

DOI: Digital Object Identifier

8651045

Related Literature

Article Analysis
・Side Effects of fenfluramine
SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.